Provision record
DocuSign · DocuSign Terms and Conditions · View original document ↗

Australia Assignment Adverse Effect Termination Right

Common · 290 of 343 platforms
Stay ahead of the changes
Track DocuSign and hear on the next check after its terms change. We check daily where we can, and show you where we can't.
Share 𝕏 Share in Share 🔒 PDF
ⓘ

This analysis describes what DocuSign's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology

How other platforms handle this

Teladoc

To the extent permitted by applicable law, the disclaimers, limitations on liability, termination and your warranties and indemnities shall survive any termination of these Terms and Conditions.

Anyscale

Neither Party may assign, transfer or novate this Agreement, by operation of law or otherwise (“ Assign ”), without the other Party’s prior written consent, provided that subject to the remainder of this Section, either Party may freely Assign this Agreement to a successor in interest upon a merger ...

Kling AI

Upon termination or expiration of this Agreement, any provision which, by its nature or express terms should survive, including but not limited to any obligations in relation to the liability of, or indemnities (if any) given by, the respective parties, will survive such termination or expiration.

See all platforms with this clause type →
▸ View Original Clause Language DOCUMENT RECORD
"
if Docusign assigns any of its rights, responsibilities or obligations under these Terms...and such assignment will have an adverse effect on you...you may terminate your Subscription Plan effective from the date the assignment comes into effect

Excerpt from DocuSign's Terms and Conditions

Provision details

Document information
Document
DocuSign Terms and Conditions
Entity
DocuSign
Date stated by the document
Jan. 13, 2025
As printed in DocuSign’s text (version CA-V-000735), not a ConductAtlas date.
Tracking information
First captured by ConductAtlas
March 19, 2026
Text quoted from version
CA-V-000735, captured April 19, 2026
Record ID
CA-P-031742
Document ID
CA-D-000197
Evidence Provenance
Source URL
Wayback Machine
Extracted-text SHA-256 (version CA-V-000735)
c2cc21ebf763cbb746605891805ea0ef65b8bdf3fdbd1d9da137474b6221524a
Analysis generated
April 27, 2026 14:12 UTC
Methodology
Evidence
✓ Excerpt found in version CA-V-000735, captured April 19, 2026 (checked Oct. 5, 2026)
Citation Record
Entity: DocuSign
Document: DocuSign Terms and Conditions
Record ID: CA-P-031742
Version: CA-V-000735
Captured: 2026-04-19 06:14:59 UTC
SHA-256: c2cc21ebf763cbb7…
URL: https://conductatlas.com/platform/docusign/docusign-terms-and-conditions/provision/CA-P-031742/australia-assignment-adverse-effect-termination-right/
Accessed: Nov. 2, 2026
Permanent archival reference. Stable identifier suitable for legal filings, compliance documentation, and research citation.
Classification
Categories

Other risks in this policy

Get the weekly coverage letter

Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.

Frequently Asked Questions

What does DocuSign's Australia Assignment Adverse Effect Termination Right clause do?

The clause states: “if Docusign assigns any of its rights, responsibilities or obligations under these Terms...and such assignment will have an adverse effect on you...you may terminate your Subscription Plan effective from the date the assignment comes into effect”

How many platforms have this type of clause?

ConductAtlas has identified this type of provision across 290 platforms. See the full comparison.

Is ConductAtlas affiliated with DocuSign?

No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by DocuSign.